Clipmarks
billparfollowshare
7-27-2009 2:58 PM
156 views
billpar says:
The House bill calls for this appointed board, dubbed the Federal Coordinating Council for Comparative Effectiveness Research, to be at least 50 percent "physicians or other experts with clinical expertise." However, there is no way the Council's 15 members - all of whom also must be employed in federal government agencies - can determine which drug or treatment is going to work .

You are a unique human being, with genetic and environmental factors influencing your health. Your sister has severe depression, and she responds only to one antidepressant. What if it isn't the one that works for most people? Or it's the most expensive one?

Peter Pitts, head of the Center for Medicine in the Public Interest and a former FDA associate commissioner, explained why "one-size-fits-all" medicine doesn't work: Most comparative effectiveness studies "don't capture the genetic variations that explain differences in response to medicines by different patients."
1 Comment   | Add a Comment
7-27-2009 3:22 PM
billpar
Having a board that excludes any treatment on the basis of comparative effectiveness is a danger to the health of those who fall outside the norms - and with the government setting those norms, any of us could end up as outliers.

The "stimulus" bill passed by the House creates this board. It allocates more than $1 billion for comparative effectiveness research. And it gives the new health and human services secretary (whoever that turns out to be) an additional $400 million at his or her discretion.

The supposed purpose of the bill - to "stimulate" the U.S. economy - is long gone.

As The New York Times's Robert Pear so eloquently put it: "For Democrats, it is also a tool for rewriting the...
Login to Comment.  Not a member yet? Sign up
Embed This Clip In Your Site...

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!

OK